Lb Pharmaceuticals LBRX
NASDAQ LBRX
$37.51 +0.23 (+0.60%)
As of: Oct 2, 2026 · 10:02 AM EDT

Lb Pharmaceuticals (LBRX) Accumulated Depreciation (2024 - 2026)

Updated

Lb Pharmaceuticals (LBRX) reported Accumulated Depreciation of $599,000 for Q2 2026, up 19.3% from the prior quarter.

Analysis

Lb Pharmaceuticals (LBRX) Accumulated Depreciation (2024 - 2026) Analysis & Trends

At the end of FY2025, Lb Pharmaceuticals posted Accumulated Depreciation of $420,000, up 315.8% from FY2024.

  • By year, Accumulated Depreciation came in at $101,000 in FY2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $502,000 (Q1 2026), $420,000 (Q4 2025) and $337,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Lb Pharmaceuticals 1.10 Bn 1.10 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 599,000.00
Mar 31, 2026 502,000.00
Dec 31, 2025 420,000.00
Sep 30, 2025 337,000.00
Dec 31, 2024 101,000.00
API Access

Lb Pharmaceuticals Accumulated Depreciation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-depreciation&ticker=LBRX&period=max&api_key=YOUR_API_KEY